Genomma Lab Internacional (OTCMKTS:GNMLF – Get Free Report) is anticipated to issue its resultson Wednesday, July 22nd. Analysts expect the company to announce earnings of $0.0308 per share and revenue of $253.9430 million for the quarter.
Genomma Lab Internacional Price Performance
Shares of OTCMKTS GNMLF opened at $0.84 on Wednesday. Genomma Lab Internacional has a twelve month low of $0.84 and a twelve month high of $1.17. The business has a fifty day simple moving average of $0.97 and a two-hundred day simple moving average of $1.01.
About Genomma Lab Internacional
Genomma Lab Internacional, SAB. de C.V. is a Mexico City–based consumer healthcare company that develops, markets and distributes over-the-counter (OTC) pharmaceuticals, personal care products and beauty solutions. Since its founding in 1996, the firm has built a diversified portfolio encompassing topical analgesics, cold and flu remedies, digestive health treatments, skin and hair care lines, and nutritional supplements. Its product mix blends proprietary brands with licensed formulas, targeting everyday wellness and self-care needs.
The company’s growth strategy hinges on intensive marketing campaigns, including television infomercials, digital advertising and direct‐to‐consumer promotions.
Featured Articles
- Five stocks we like better than Genomma Lab Internacional
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Receive News & Ratings for Genomma Lab Internacional Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genomma Lab Internacional and related companies with MarketBeat.com's FREE daily email newsletter.
